Is Psoriatic Arthritis Hereditary? Risks, Testing, Diagnosis
Healthline· 4 days agoPsoriatic arthritis (PsA) is a type of arthritis that affects some people with psoriasis, an...
UCB Announces First Detailed Data from Two Phase 3 Bimekizumab Studies in Psoriatic Arthritis to be...
WDBJ 7 Roanoke· 5 days agoFirst presentations from the BE OPTIMAL and BE COMPLETE studies evaluating bimekizumab in the treatment of adults with active psoriatic arthritis who were ...
Psoriatic arthritis support group: How to find the right one
Medical News Today· 5 days agoPsoriatic arthritis (PsA) support groups can help a person living with PsA feel understood. Support...
Apremilast for athletes: Side effects, risks, and safety
Medical News Today· 4 days agoPsoriatic arthritis (PsA) can cause swollen and tender joints. It often affects people with...
AbbVie Showcases its Leadership in Rheumatology Research with New Data Across Multiple Inflammatory...
News 12 Augusta· 4 days ago- SELECT-AXIS 2 highlights the efficacy and safety data of upadacitinib (RINVOQ®) in patients with non-radiographic axial spondyloarthritis, and in patients with radiographic axial spondyloarthritis ...
CHMP Recommends European Commission Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults...
1011 News· 6 days agoCHMP positive opinion is based on results from three Phase 3 studies: two for induction and one for maintenance1-3Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease ...
What I Wish Everyone Knew About Psoriatic Arthritis and Psoriasis
WebMD· 2 days agoImportant: The opinions expressed in WebMD Blogs are solely those of the User, who may or may not...
Novartis (NVS) Cosentyx Gets Positive CHMP Opinion for JIA
Zacks via Yahoo Finance· 5 days agoCHMP recommended the approval of the drug used alone or in combination with methotrexate, in the...
The Best Habits To Follow When Dealing With Arthritis, Expert Says — Eat This Not That
Eat This, Not That!· 5 days agoArthritis is a common, painful disorder many people live with on the regular. In fact, 58.5 million...
SVB Leerink Begins Coverage on Amgen (NASDAQ:AMGN)
ETF DAILY NEWS· 5 days agoResearch analysts at SVB Leerink began coverage on shares of Amgen (NASDAQ:AMGN – Get Rating) in a report released on Monday, The Fly reports. The brokerage set a “market perform” rating and ...